# Grace Therapeutics, Inc.: Form 8-K, filed Apr 27, 2026

- Company: [Grace Therapeutics, Inc.](/companies/grce.md) (CIK 1444192)
- Form: 8-K
- Filed: 2026-04-27
- Accepted by EDGAR: Apr 27, 2026, 07:08 ET
- Period: 2026-04-27
- Accession: 0001140361-26-016834
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1444192/000114036126016834/ef20071554_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1444192/000114036126016834/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1444192/000114036126016834/ef20071554_8k.htm

Filed Apr 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-016834. Last ingested by Listed: Nov 6, 2026, 02:04 ET. No prices; not investment advice.